Electro-Optical Sciences, Inc, Irvington, New York, announced that the US Food and Drug Administration (FDA) formally accepted for filing the company's premarket approval (PMA) application for MelaFind, a noninvasive and objective computer vision system intended to aid in the early detection of melanoma. The FDA's action means that the PMA application was sufficiently complete and ready for substantive review.

[black up pointing small triangle] Information:http://www.eosciences.com